Wordt geladen...

Review of intravenous immunoglobulin replacement therapy trials for primary humoral immunodeficiency patients

An available supply of intravenous immunoglobulin (IVIG) is essential for individuals with primary humoral immunodeficiency. A shortage in 1997 prompted the Food and Drug Administration (FDA) to revise guidelines for the licensure, production, and distribution of new IVIG products, including the sta...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteurs: Schroeder, H. W., Dougherty, C. J.
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Springer-Verlag 2012
Onderwerpen:
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3501191/
https://ncbi.nlm.nih.gov/pubmed/22968971
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s15010-012-0323-9
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!